Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-16-651834
Filing Date
2016-07-20
Accepted
2016-07-20 09:15:38
Documents
5
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d73525d10ka.htm 10-K/A 107157
2 EX-10.11 d73525dex1011.htm EX-10.11 391747
3 EX-31.5 d73525dex315.htm EX-31.5 2195
4 EX-31.6 d73525dex316.htm EX-31.6 2415
5 GRAPHIC g73525g37r19.jpg GRAPHIC 4402
  Complete submission text file 0001193125-16-651834.txt   510850
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37471 | Film No.: 161774666
SIC: 8731 Services-Commercial Physical & Biological Research